A PMMA bone cement with improved antibacterial function and flexural strength.

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Infectious Disease Research

Background:

• Bone cement infections pose a significant clinical challenge.
• Conventional bone cements lack inherent antibacterial properties.
• Development of effective, non-leaching antibacterial bone cements is crucial.

Purpose of the Study:

• To synthesize and evaluate a novel non-leaching antibacterial bone cement.
• To assess the mechanical properties and antibacterial efficacy of the modified cement.
• To investigate the impact of antibacterial moiety content, filler particle size, and loading.

Main Methods:

• Synthesized an antibacterial furanone derivative and coated it onto alumina filler particles.
• Incorporated coated alumina into conventional poly(methyl methacrylate) bone cement.
• Evaluated flexural strength, flexural modulus, and bacterial viability (S. aureus, E. coli).

Main Results:

• Modified cements exhibited enhanced flexural strength (up to 10%) and modulus (up to 18%).
• Significant antibacterial activity observed: up to 67% against S. aureus and 84% against E. coli.
• Antibacterial activity increased with moiety content and filler loading; decreased with larger particle size. No significant leaching detected.

Conclusions:

• The novel non-leaching antibacterial bone cement demonstrates promising mechanical and antibacterial properties.
• This modified poly(methyl methacrylate) bone cement has potential for clinical use in reducing surgical site infections.
• Further development could lead to a safer and more effective bone void filler.